- Home
- TRVI vs CCU Comparison
TRVI vs CCU Comparison
Compare TRVI & CCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRVI | CCU |
|---|---|---|
| Founded | 2011 | 1850 |
| Country | United States | Chile |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | 2019 | 2001 |
Fundamental Metrics
Financial Performance| Metric | TRVI | CCU |
|---|---|---|
| Price | $17.23 | $11.78 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 11 | 2 |
| Target Price | ★ $21.55 | $12.00 |
| AVG Volume (30 Days) | ★ 1.4M | 127.7K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.90% |
| EPS Growth | ★ 31.91 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.42 |
| Revenue Next Year | N/A | $4.71 |
| P/E Ratio | ★ N/A | $18.35 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.98 | $10.71 |
| 52 Week High | $20.22 | $15.36 |
Technical Indicators
Market Signals| Indicator | TRVI | CCU |
|---|---|---|
| Relative Strength Index (RSI) | 41.56 | 51.89 |
| Support Level | $16.24 | $11.41 |
| Resistance Level | $19.30 | $12.13 |
| Average True Range (ATR) | 0.75 | 0.37 |
| MACD | -0.19 | -0.06 |
| Stochastic Oscillator | 26.70 | 40.89 |
Price Performance
Historical ComparisonAbout TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.
About CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.